Cerebrosterol

Cerebrosterol is a lipid of Sterol Lipids (ST) class. Cerebrosterol is associated with abnormalities such as nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Senile Plaques and Hypercholesterolemia. The involved functions are known as Blood - brain barrier function, Oxidation, 5-(carboxyamino)imidazole ribonucleotide mutase activity, cholesterol biosynthetic process and Anabolism. Cerebrosterol often locates in Hepatic, Body tissue, Autosome, brain tissue surgical material and Tissue membrane. The associated genes with Cerebrosterol are CYP27A1 gene, Alleles, INS gene, Apolipoprotein E4 and PLXNB1 gene. The related lipids are Sterols, 7-dehydrocholesterol, 27-hydroxycholesterol, 24-hydroxycholesterol and Dehydrocholesterols. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Cerebrosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cerebrosterol?

Cerebrosterol is suspected in Hypercholesterolemia, nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Primary open angle glaucoma, Hypertensive disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cerebrosterol

MeSH term MeSH ID Detail
Alzheimer Disease D000544 76 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Nerve Degeneration D009410 53 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Cerebrosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cerebrosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cerebrosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cerebrosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Cerebrosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cerebrosterol?

Mouse Model

Mouse Model are used in the study 'Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.' (Valenza M et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Cerebrosterol

Download all related citations
Per page 10 20 50 100 | Total 193
Authors Title Published Journal PubMed Link
Papassotiropoulos A et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. 2005 J Clin Psychiatry pmid:16013913
Solfrizzi V et al. Circulating biomarkers of cognitive decline and dementia. 2006 Clin. Chim. Acta pmid:16139826
Karrenbauer VD et al. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. 2006 Clin Neurol Neurosurg pmid:16144738
Thelen KM et al. Effect of pravastatin on plasma sterols and oxysterols in men. 2006 Eur. J. Clin. Pharmacol. pmid:16385401
Leoni V et al. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? 2006 Apr 10-17 Neurosci. Lett. pmid:16406316
Abildayeva K et al. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. 2006 J. Biol. Chem. pmid:16524875
Panzenboeck U et al. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. 2006 Int. J. Biochem. Cell Biol. pmid:16530456
Kölsch H et al. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. 2006 Int. J. Mol. Med. pmid:16596262
Lukiw WJ Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease. 2006 Expert Rev Neurother pmid:16734516
Thelen KM et al. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. 2006 J Clin Pharmacol pmid:16809807
He X et al. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. 2006 J. Neuropathol. Exp. Neurol. pmid:16825952
Lütjohann D Cholesterol metabolism in the brain: importance of 24S-hydroxylation. 2006 Acta Neurol. Scand., Suppl.c pmid:16866909
Björkhem I et al. Oxysterols and Alzheimer's disease. 2006 Acta Neurol. Scand., Suppl.c pmid:16866910
Fujiyoshi M et al. 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. 2007 J. Neurochem. pmid:17101031
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. 2006 J. Intern. Med. pmid:17116000
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Karu K et al. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. 2007 J. Lipid Res. pmid:17251593
Björkhem I Rediscovery of cerebrosterol. 2007 Lipids pmid:17393206
Teunissen CE et al. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. 2007 J. Neurosci. Res. pmid:17410599
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Joffre C et al. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. 2007 Curr. Eye Res. pmid:17453947
Khripach VA et al. [A new synthesis of cerebrosterol and its 24-epimer from lithocholic acid]. 2007 Mar-Apr Bioorg. Khim. pmid:17476989
Famer D et al. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. 2007 Biochem. Biophys. Res. Commun. pmid:17532301
Valenza M et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. 2007 Hum. Mol. Genet. pmid:17613541
Kristofiková Z et al. Complex of amyloid beta peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. 2008 Neurochem. Res. pmid:17717740
Shafaati M et al. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. 2007 Neurosci. Lett. pmid:17822846
Ohtsuki S et al. Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier. 2007 J. Neurochem. pmid:17868302
Umetani M et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. 2007 Nat. Med. pmid:17873880
Koschack J et al. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. 2009 Neurobiol. Aging pmid:18061309
Wang Y et al. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. 2008 J. Proteome Res. pmid:18303831
DeBarber AE et al. Liquid chromatography-tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol. 2008 Anal. Biochem. pmid:18555788
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
Leoni V et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. 2008 Brain pmid:18772220
Honda A et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. 2009 J. Lipid Res. pmid:18815436
Rantham Prabhakara JP et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. 2008 J. Neurochem. pmid:19014385
Bang HJ et al. A comparison of the potential unfavorable effects of oxycholesterol and oxyphytosterol in mice: different effects, on cerebral 24S-hydroxychoelsterol and serum triacylglycerols levels. 2008 Biosci. Biotechnol. Biochem. pmid:19060413
Prasanthi JR et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. 2009 Mol Neurodegener pmid:19126211
Leoni V Oxysterols as markers of neurological disease--a review. 2009 Scand. J. Clin. Lab. Invest. pmid:19199127
Kölsch H et al. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. 2009 Eur. Psychiatry pmid:19286353
Liao WL et al. Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry. 2009 Biochemistry pmid:19317426
Seet RC et al. Oxidative damage in dengue fever. 2009 Free Radic. Biol. Med. pmid:19427377
Shafaati M et al. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo. 2010 J. Lipid Res. pmid:19474457
Fourgeux C et al. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19553612
Solomon A et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. 2009 Neurosci. Lett. pmid:19560513
Cook IT et al. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation. 2009 Drug Metab. Dispos. pmid:19589875
Hudry E et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. 2010 Mol. Ther. pmid:19654569
Zhao S et al. Polar metabolite of cholesterol induces rat cognitive dysfunctions. 2009 Neuroscience pmid:19699274
Cartagena CM et al. 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. 2010 Brain Res. pmid:20053345
Wang Y et al. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). 2010 Biochim. Biophys. Acta pmid:20211758